D-0219-2024 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0219-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Dec 15, 2023 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules. The recall status is terminated (terminated Sep 16, 2024). Affected quantity: 8,280 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 17, 2024
Initiation Date
Dec 15, 2023
Termination Date
Sep 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,280 bottles

Product description

Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01

Reason for recall

Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Distribution pattern

US Nationwide.

Code information

Lot# C2307275; Exp. January 2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0219-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0219-2024. Report a data issue: hello@regdatalab.com.